company background image
NSTM logo

NovelStem International OTCPK:NSTM Stock Report

Last Price

US$0.07

Market Cap

US$3.3m

7D

14.8%

1Y

-65.0%

Updated

24 Mar, 2024

Data

Company Financials

NovelStem International Corp.

OTCPK:NSTM Stock Report

Market Cap: US$3.3m

NSTM Stock Overview

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy.

NSTM fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

NovelStem International Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NovelStem International
Historical stock prices
Current Share PriceUS$0.07
52 Week HighUS$0.28
52 Week LowUS$0.06
Beta0.13
1 Month Change6.06%
3 Month Change11.29%
1 Year Change-65.00%
3 Year Change-75.00%
5 Year Change-22.22%
Change since IPO-99.18%

Recent News & Updates

Recent updates

Shareholder Returns

NSTMUS BiotechsUS Market
7D14.8%-0.06%2.1%
1Y-65.0%9.8%30.4%

Return vs Industry: NSTM underperformed the US Biotechs industry which returned 9.8% over the past year.

Return vs Market: NSTM underperformed the US Market which returned 30.4% over the past year.

Price Volatility

Is NSTM's price volatile compared to industry and market?
NSTM volatility
NSTM Average Weekly Movementn/a
Biotechs Industry Average Movement11.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.0%

Stable Share Price: NSTM has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine NSTM's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993n/an/ahttps://www.novelstem.com

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is based in Boca Raton, Florida.

NovelStem International Corp. Fundamentals Summary

How do NovelStem International's earnings and revenue compare to its market cap?
NSTM fundamental statistics
Market capUS$3.28m
Earnings (TTM)-US$1.29m
Revenue (TTM)n/a

0.0x

P/S Ratio

-2.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NSTM income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$1.29m
Earnings-US$1.29m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.028
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio9.7%

How did NSTM perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.